| Company Name: |
Tianjin Kailiqi Biotechnology Co., Ltd.
|
| Tel: |
15076683720 |
| Email: |
klq@cw-bio.com |
| Products Intro: |
Product Name:GAC0003A4
CAS:929492-71-7
Purity:大于98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:GAC0003A4
CAS:929492-71-7
Purity:98.41% Package:1mg/RMB 965;5mg/RMB 2390;10mg/RMB 3820
|
1-(3,5-dimethoxybenzoyl)-4-(2-methylphenyl)piperazine manufacturers
- GAC0003A4
-
- $67.00 / 1mg
-
2025-11-10
- CAS:929492-71-7
- Min. Order:
- Purity: 98.41%
- Supply Ability: 10g
|
| | 1-(3,5-dimethoxybenzoyl)-4-(2-methylphenyl)piperazine Basic information |
| | 1-(3,5-dimethoxybenzoyl)-4-(2-methylphenyl)piperazine Chemical Properties |
| form | Solid | | color | White to off-white |
| | 1-(3,5-dimethoxybenzoyl)-4-(2-methylphenyl)piperazine Usage And Synthesis |
| Description | GAC0001E5 is a novel LXR inverse agonist, functioning as LXR a "degrader", significantly reducing LXR protein levels in PDAC cell lines. | | Uses | GAC0003A4 is an LXR inverse agonist that inhibits LXR transcriptional activity. GAC0003A4 also efficiently degrades LXRβ protein. GAC0003A4 has the potential to be used in advanced pancreatic cancer and other refractory malignancies[1]. | | References | [1] Karaboga H, et al. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity. ACS Chem Biol. 2020 Nov 20;15(11):2916-2928. DOI:10.1021/acschembio.0c00546 |
| | 1-(3,5-dimethoxybenzoyl)-4-(2-methylphenyl)piperazine Preparation Products And Raw materials |
|